Share on StockTwits

Uroplasty (NYSE:UPI) Director Kevin H. Roche bought 10,000 shares of Uroplasty stock in a transaction that occurred on Tuesday, June 3rd. The shares were purchased at an average cost of $2.97 per share, for a total transaction of $29,700.00. Following the transaction, the director now directly owns 10,000 shares of the company’s stock, valued at approximately $29,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Uroplasty (NYSE:UPI) traded down 1.71% on Wednesday, hitting $2.88. The stock had a trading volume of 156,010 shares. Uroplasty has a 52-week low of $1.69 and a 52-week high of $5.40. The stock has a 50-day moving average of $3.16 and a 200-day moving average of $3.47. The company’s market cap is $61.5 million.

Uroplasty (NYSE:UPI) last announced its earnings results on Thursday, May 15th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.01. During the same quarter in the previous year, the company posted ($0.05) earnings per share. On average, analysts predict that Uroplasty will post $-0.20 earnings per share for the current fiscal year.

Uroplasty, Inc is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.